Nociception and the Neonatal Brain
Overview
Pediatrics
Affiliations
Measuring brain activity in infants provides an objective surrogate approach with which to infer pain perception following noxious events. Here we discuss different approaches which can be used to measure noxious-evoked brain activity, and discuss how these measures can be used to assess the analgesic efficacy of pharmacological and non-pharmacological interventions. We review factors that can modulate noxious-evoked brain activity, which may impact infant pain experience, including gestational age, sex, prior pain, stress, and illness.
Depression of cortical neuronal activity after a low-dose fentanyl in preterm infants.
Nilsson S, Tokariev A, Vehvilainen T, Fellman V, Vanhatalo S, Norman E Acta Paediatr. 2024; 114(1):109-115.
PMID: 39258825 PMC: 11627449. DOI: 10.1111/apa.17411.
Bulut O, Topaloglu S, Bulut N, Hocaoglu M, Arslanoglu S J Perinatol. 2024; 44(11):1675-1681.
PMID: 39134667 PMC: 11518980. DOI: 10.1038/s41372-024-02081-4.
Biomarkers for assessing pain and pain relief in the neonatal intensive care unit.
Ten Barge J, Baudat M, Meesters N, Kindt A, Joosten E, Reiss I Front Pain Res (Lausanne). 2024; 5:1343551.
PMID: 38426011 PMC: 10902154. DOI: 10.3389/fpain.2024.1343551.
Thill B Front Pain Res (Lausanne). 2023; 4:1128530.
PMID: 37025166 PMC: 10072285. DOI: 10.3389/fpain.2023.1128530.
The missing mechanistic link: Improving behavioral treatment efficacy for pediatric chronic pain.
Jotwani M, Wu Z, Lunde C, Sieberg C Front Pain Res (Lausanne). 2022; 3:1022699.
PMID: 36313218 PMC: 9614027. DOI: 10.3389/fpain.2022.1022699.